Question 1

During spironolactone therapy,the blood levels of ________ should be monitored.

Accepted Answer

A)  sodium 
B)  potassium 
C)  urea 
D)  calcium 
A)  sodium 
B)  potassium 
C)  urea 
D)  calcium B

Question 2

Which one of the following effects is not associated with adrenocorticoid hormones?

Accepted Answer

A)  An increase in blood glucose levels 
B)  Sodium and water retention 
C)  The enhancement of immune processes 
D)  The distribution of body hair 
A)  An increase in blood glucose levels 
B)  Sodium and water retention 
C)  The enhancement of immune processes 
D)  The distribution of body hair C

Question 3

A specific immune-related effect associated with glucocorticoid action is:

Accepted Answer

A)  destabilisation of T lymphocytes. 
B)  increased protein synthesis. 
C)  increase in neutrophil and macrophage response. 
D)  reduction in the size and substance of the lymph nodes and spleen. 
A)  destabilisation of T lymphocytes. 
B)  increased protein synthesis. 
C)  increase in neutrophil and macrophage response. 
D)  reduction in the size and substance of the lymph nodes and spleen. D

Question 4

Which of the following corticosteroids is classified as an intermediate-acting agent?

Accepted Answer

A)  Hydrocortisone 
B)  Dexamethasone 
C)  Prednisolone 
D)  Betamethasone 
A)  Hydrocortisone 
B)  Dexamethasone 
C)  Prednisolone 
D)  Betamethasone

Question 5

Which of the following is an example of a long-acting corticosteroid?

Accepted Answer

A)  Dexamethasone 
B)  Cortisone 
C)  Prednisone 
D)  Budesonide 
A)  Dexamethasone 
B)  Cortisone 
C)  Prednisone 
D)  Budesonide

Question 6

The glucocorticoids have a role in the therapy associated with:

Accepted Answer

A)  diabetes mellitus. 
B)  osteoporosis. 
C)  hypovolaemic shock. 
D)  hypertension. 
A)  diabetes mellitus. 
B)  osteoporosis. 
C)  hypovolaemic shock. 
D)  hypertension.

Question 7

A typical adverse effect profile of systemic corticosteroid therapy includes:

Accepted Answer

A)  hyperkalaemia, gynaecomastia, skin rashes and menstrual disruption. 
B)  hot flushes, thromboembolism, leg cramps and gastrointestinal disturbances. 
C)  nausea, breast tenderness, hypotension and hypoglycaemia. 
D)  fluid retention, altered mood, altered blood pressure, hypokalaemia, hyperglycaemia and impaired wound healing. 
A)  hyperkalaemia, gynaecomastia, skin rashes and menstrual disruption. 
B)  hot flushes, thromboembolism, leg cramps and gastrointestinal disturbances. 
C)  nausea, breast tenderness, hypotension and hypoglycaemia. 
D)  fluid retention, altered mood, altered blood pressure, hypokalaemia, hyperglycaemia and impaired wound healing.

Question 8

When the oral dose exceeds 	mg daily of prednisolone or equivalent dose,the person will benefit from receiving gastric acid-suppressive therapy.

Accepted Answer

A)  4 
B)  6 
C)  10 
D)  15 
A)  4 
B)  6 
C)  10 
D)  15

Exam 62: Medicines Affecting the Adrenal Cortex

During spironolactone therapy,the blood levels of ________ should be monitored.

Which one of the following effects is not associated with adrenocorticoid hormones?

A specific immune-related effect associated with glucocorticoid action is:

Which of the following corticosteroids is classified as an intermediate-acting agent?

Which of the following is an example of a long-acting corticosteroid?

The glucocorticoids have a role in the therapy associated with:

A typical adverse effect profile of systemic corticosteroid therapy includes:

When the oral dose exceeds mg daily of prednisolone or equivalent dose,the person will benefit from receiving gastric acid-suppressive therapy.

Sociocultural Aspects

Health Professionals and the Law

Ethical Issues

the Roles and Responsibilities of Health Professionals in Medicine Adherence, Education and Advocacy

the Roles and Responsibilities of Health Professionals in Medicine Management

Medicine Formulations, Storage and Routes of Administration

the Clinical Decision-making Process

Medicine Administration Strategies and Documentation

Medication Errors

Management of Common Adverse Drug Reactions

Risk Communication: Balancing the Benefits and Risks of Drug Treatment

Drug Nomenclature

Pharmacokinetics: Absorption and Distribution

Pharmacokinetics Metabolism and Excretion

Drug Interactions

Pharmacodynamics

Drug Development, Evaluation and Safety

Genetic Considerations in Pharmacology

Pharmacokinetic Factors That Modify Drug Action

Paediatric and Geriatric Pharmacology

Poisoning and Envenomation

the Management of Acute Clinical Overdose

Contemporary Drugs of Abuse

Drug Abuse in Sport

General Aspects of Neuropharmacology

Adrenergic Pharmacology

Cholinergic Pharmacology

An Introduction to Chemical Mediators

Histamine and Antihistamines

Prostaglandins and Serotonin

Nitric Oxide and the Endothelins

General concepts of Psychopharmacology

Antipsychotics

Anxiolytics and Hypnotics

Antidepressants and Mood Stabilisers

Medicines Used in Neurodegenerative Disorders

Antiseizure Agents and Muscle Relaxants

Central Nervous System Stimulants

Opioid Analgesics

Anti-inflammatory, Antipyretic and Non-opioid Analgesic Agents

Medicines Used to Treat Migraine

General Anaesthesia

Local Anesthesia

Medicines Used to Lower Blood Lipids

Antihypertensive Agents

Medicines Used to Promote Tissue Perfusion

Antithrombotic, Fibrinolytic and Haemostatic Agents

Diuretics and Other Renal Medicines

Topic: Medicines Used to Treat Heart Failure

Medicines Used to Treat Cardiac Dysrhythmia

Fluid and Potassium Imbalances

Antianaemic Agents

Medicines Used to Maintain Gas Exchange

Medicines for Upper Respiratory Tract Conditions

Upper Gastrointestinal Tract Medicines

Lower Castrointestinal Tract Medicines

Antiemetic Agents

Enteral and Parenteral Nutrition

Medicines and the Pituitary Gland

Medicines and the Thyroid

Medicines and the Pancreas

Medicines and the Gonads

Medicines and Bone Metabolism

Hyperuricaemia and Gout

Obesity and Its Treatment

Introduction to Chemotherapy

Sulfonamides and Trimethoprim

Antibacterial Agents

Antituberculotic and Antileprotic Agents

Antiseptics and Disinfectants

Antiparasitic Agents